Find a Viewpoint

Antimicrobial Viewpoints are articles in which experts in different areas of antimicrobial resistance share their knowledge and opinions about the current status and the future challenges of this field. You can read our editorial and ethics policies for these articles here

<br>Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials?</br><em> – by Stephen Senn</em>
13 August 2021

Trials of COVID-19 vaccines: what can be learnt for the development of new antimicrobials? – by Stephen Senn

more
<br>Strengthening the regulation of antimicrobial use to mitigate drug resistance</br><em> – by Maarten van der Heijden</em>
16 July 2021

Strengthening the regulation of antimicrobial use to mitigate drug resistance – by Maarten van der Heijden

more
<br>Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis</br><em> – by Phoebe Williams, Nina Putri and Gayana Gunaratna</em>
17 June 2021

Addressing the knowledge gaps surrounding AMR infections in neonatal sepsis – by Phoebe Williams, Nina Putri and Gayana Gunaratna

more
<br>Rapid diagnostic tests to support clinical trials of antibiotics</br><em> – by Gian Maria Rossolini</em>
2 June 2021

Rapid diagnostic tests to support clinical trials of antibiotics – by Gian Maria Rossolini

more
<br>Will new antibiotic classes solve multidrug resistance?</br><em> – by Michael N. Dudley and Olga Lomovskaya</em>
21 May 2021

Will new antibiotic classes solve multidrug resistance? – by Michael N. Dudley and Olga Lomovskaya

more
<br>Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance</br><em> – by Matthew E. Levison</em>
26 April 2021

Introducing ProMED-AMR, the new ProMED network for antimicrobial resistance – by Matthew E. Levison

more

Share

FacebookTwitterLinkedInEmail
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top